Hemodynamic Performance In-Vivo of a New Ventricular Assist Device

Nowadays, circulatory support has become a common practice in medicine and a standard in the treatments of cardio vascular disease (CVD). A new pneumatic ventricular assist device (VAD) has been developed in Mexico City. This paper shows the first results of acute in-vivo trials, intended to verify...

Full description

Saved in:
Bibliographic Details
Published in2005 IEEE Engineering in Medicine and Biology 27th Annual Conference Vol. 2006; pp. 394 - 397
Main Authors Corona, F., Barragan, R., Calderon, M., Martinez, H., Infante, O., Molina, J., Lespron, C., Hernandez, A., Escobedo, C., Catrip, J., Gorzelewski, A., Tena, C., Graullera, V., Sacristan, E.
Format Conference Proceeding Journal Article
LanguageEnglish
Published United States IEEE 2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Nowadays, circulatory support has become a common practice in medicine and a standard in the treatments of cardio vascular disease (CVD). A new pneumatic ventricular assist device (VAD) has been developed in Mexico City. This paper shows the first results of acute in-vivo trials, intended to verify the new system for providing physiological flows and pressures. Two VADs were implanted to as right (RVAD), left (LVAD) support in a 65 kg pig. The support time was 20 minutes with RVAD, 20 minutes with LVAD and 20 minutes with biventricular (BiVAD). The VAD proved its capability to maintain physiological parameters during the support time. We are satisfied with the results of this trial, and we believe this study will ascertain the first step on the next phase of in-vivo trials
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISBN:0780387414
9780780387416
ISSN:1094-687X
1557-170X
1558-4615
DOI:10.1109/IEMBS.2005.1616428